
August
2004
| Proposals and Awards |
|
October
1 -- MAJOR Proposal Deadline! American Association of Critical Care Nurses American Association for Dental Research American Cancer Society (ACS) American College of Obstetricians and Gynecologists (ACOG) American Diabetes Association (ADA) American Lung Association Burroughs Wellcome Fund Centers for Disease Control Cystic Fibrosis Foundation Guggenheim Memorial Foundation Helene Fuld Health Trust Leukemia & Lymphoma Society March of Dimes National Historical Publications & Records Commission (NHPRC) National Institute of Justice National Institute of Standards and Technology (NIST) National Institutes of Health (NIH) National Science Foundation (NSF) National Endowment for the Humanities (NEH) National Multiple Sclerosis Society Pfizer, Inc. PhRMA Research Corporation Robert Wood Johnson Foundation Whitehall Foundation U.S. Department of Agriculture U.S. Department of Defense U.S. Department of Justice |
| Sponsored Program Development |
|
R&SP
Announces Oct 15 Internal Funding Deadline and Revised Guidelines OPD Announces Oct 15 Internal Funding Deadline and Revised Terms of Eligibility Grant-in-Aid for Special Populations Grant-in-Aid for Academic Staff Development: Funding of up to $1000 is available to provide support for professional development and training that is related to roles and responsibilities at the university. Grant-in-Aid for Associate (Part-time) Faculty and Lecturer Development: Funding of up to $1000 is available for professional development, including participation in scholarly meetings. Grant-in-Aid for Women Faculty Development: Funding of up to $3000 is available to support activities for career advancement and enhancement for women faculty. General
Grant-in-Aid Gateway
(Special Focus) Course Grant Project areas
include: This committee funds grants that promise innovative approaches or improved practice in assessment and/or program review. PRAC invites groups or individuals to submit proposals for initiatives that support the continued development of school/departmental assessment plans that focus on enhancing student learning and/or assessment of program effectiveness in connection with preparing the self-study for program review. |
| Human Subjects |
| New
SOP Under Development to Clarify Specimen-Banking Protocols and the
IRB Requirements HIPAA requires that subjects be provided with specific information regarding the future use of their specimens if their samples are identifiable and such information is typically shared via the informed consent statement for the research project. (For studies which involve de-identified specimens, this issue does not apply. De-identified specimens may be used for broader purposes with appropriate IRB approval.) For example, in a cancer study, subjects might be told in the informed consent that their specimens will be used “in relation to future research about cancer” and this would be HIPAA-compliant. In contrast, The Common Rule allows for subjects to be given a generic statement regarding what might be done with their specimens. Using the same above example, The Common Rule would allow that subjects be told in an informed consent that their samples will be used “in relation to future research about cancer and other unspecified projects.” Therefore, a disconnect exists between what HIPAA and The Common Rule require. In cases of biomedical research, IUPUI and Clarian are obviously bound by the HIPAA regulations and since these regulations are stricter than what is prescribed by The Common Rule for such studies, IUPUI and Clarian IRBs must be compliant with HIPAA requirements. Thus, the IUPUI and Clarian IRBs require that for studies which involve the banking of identifiable samples, subjects must either be given “specific” information about what their samples might be used for in the future or they must be provided a subsequent informed consent when new uses are proposed with their samples that have not been previously described to them in an informed consent statement. As a side note, for research involving specimens from deceased individuals, HIPAA allows that such specimens may be used for any purpose as long as the investigator can document that the individual is deceased. An exempt research application, however, will need to be submitted for IRB acceptance in order to proceed with the use. A Standard Operating Procedure (SOP) is forthcoming which will provide more specific guidance for investigators regarding the conduct of such studies at IUPUI/Clarian. Watch the R&SP Communicator (http://www.iupui.edu/~resgrad/newsletter.htm) for developing information. |
| What's New |
| Registration
Now Open for the Oct 18 Grant Writing Workshop Rather than offer what is typically presented (little more than how to fill out forms and conform to instructions) the grant writing seminar emphasizes idea development, how to write for reviewers and tips and strategies. The program design is both educational and entertaining. Discussions, practical exercises, morning, afternoon and lunch breaks, and a detailed handout ensure that participants will find this an effective and informative program. To view the program brochure and register, go to http://cme.medicine.iu.edu/courses/grantwriting/default.htm. |
| Submit
Your News to the R&SP Communicator Deadline for
R&SP Communicator news article submission: R&SP Communicator
readers: Shannon Walden Coordinator of Educational Programs for Responsible Conduct in Research UN 618 620 Union Drive, Room 618 Indianapolis, IN 46202-5167 Phone - (317) 274-8285 Fax - (317) 274-8744 E-mail: sfwalden@iupui.edu |
|
Send COMMENTS,
QUESTIONS to: |
Research
and Sponsored Programs
UN 618 General - 317 274-8285 Research Compliance - 317 274-8289 Sponsored Program Development - 317 278-0249 |